During the past decade, Ematologia - Sapienza Università di Roma conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Ematologia - Sapienza Università di Roma" are "Chronic Myeloid Leukaemia" (1 trials) and "Chronic Myeloid Leukemia" (1 trials). Many other conditions were trialed in "Ematologia - Sapienza Università di Roma" in a lesser frequency.

Most popular intervention types in "Ematologia - Sapienza Università di Roma" are "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "HRQOL questionnaire" (1 trials) and "Imatinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ematologia - Sapienza Università di Roma" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Ematologia - Sapienza Università di Roma". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Ematologia - Sapienza Università di Roma, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ematologia - Sapienza Università di Roma, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".